Skip to main content

Aptus Capital Advisors, LLC

Position in AMGN — Amgen Inc

CIK 1664193 FAIRHOPE, AL

Position in AMGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$15,485,699
+$895,887 QoQ
Shares Held
42,764
+3.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#429
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in AMGN Over Time

Shares Held

Position Value (USD)

Derivatives in AMGN

reported options exposure · as of Sep 30, 2020
CallValue
$17,791,200
CallShares
70,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Aptus Capital Advisors, LLC holds $223,621,682 across 14 Drug Manufacturers - General names. AMGN ranks #5 (6.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 AMGN
Amgen Inc
This page
42,764 $15,485,699

All Filings in AMGN

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,485,699 42,764
2026-03-31 $14,589,812 41,466
2025-12-31 $14,621,265 44,671
2025-09-30 $12,526,011 44,387
2025-06-30 $12,824,952 45,933
2025-03-31 $14,829,780 47,600
2024-12-31 $11,367,292 43,613
2024-09-30 $8,774,744 27,233
2024-06-30 $6,785,789 21,718
2024-03-31 $4,989,531 17,549
2023-12-31 $5,624,454 19,528
2023-09-30 $5,247,807 19,526
2023-06-30 $4,389,113 19,769
2023-03-31 $504,290 2,086
2022-12-31 $3,276,959 12,477
2022-09-30 $485,060 2,152
2022-06-30 $530,637 2,181
2022-03-31 $481,463 1,991
2021-12-31 $224,295 997
2021-09-30 $2,160,524 10,160
2021-06-30 $4,155,206 17,047
2021-03-31 $3,893,378 15,648
2020-12-31 $3,592,040 15,623
2020-09-30 $3,348,812 13,176
2020-09-30 $17,791,200 70,000
2020-06-30 $3,004,384 12,738
2020-03-31 $2,369,102 11,686